Article ID Journal Published Year Pages File Type
3383245 Reumatología Clínica 2010 6 Pages PDF
Abstract
This comparative clinical study in patients with SLE shows that rituximab can be as useful as cyclophosphamide for severe manifestations, maybe showing a faster response. Adverse events were no different. Rituximab should be considered as an adequate alternative for this group of patients.
Related Topics
Health Sciences Medicine and Dentistry Immunology, Allergology and Rheumatology
Authors
, , , , , , , , ,